Antituberculosis Agents X. Synthesis and Evaluation of In Vitro Antituberculosis Activity of 2-(5-Nitro-2-furyl)-and 2-(1-Methyl-5-nitro-1H-imidazol-2-yl)-1 ,3,4-thiadiazole Derivatives
![]() ![]() |
Alireza-Foroumadi
(Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran)
Fatemeh-Soltani (Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Ira) Raheleh-Jabini (Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Ira) Moshafi, Mohammad-Hasan (Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Ira) Rasnani, Fatemeh-Mohammadian (Department of Medicinal Chemistry, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Ira) |
1 | Foroumadi, A., Mirzaei, M., and Shafiee, A., Antituberculosis agents I: synthesis and antituberculosis activity of 2-ary-1,3,4-thiadiazole derivatives. Pharmazie, 56, 610-612 (2001a) PUBMED |
2 | Kaufmann, S. H., Protection against tuberculosis: cytokines, T cells, and macrophages. Ann. Rheum. Dis., 61 (Suppl. 2), ii 54-58 (2002) |
3 | Rollas, S., Karakus, S., Durgun, B. B., Kiraz M., and Erdeniz, H., Synthesis and antimicrobial activity of some 1,4-disubstituted thiosemicarbazide and 2,5-disubstituted 1,3,4-thiadiazole derivatives. Farmaco, 51, 811-814 (1996) |
4 | Pasqualoto, K. F. and Ferreira, E. I. An approach for the rational design of new antituberculosis agents. Curr. Drug Targets, 2, 427-437 (2001) DOI ScienceOn |
5 | Tsotinis, A., Varvaresou, A., Calogeropoulou, T., and Siatra-Papasta Tiligada, A., Synthesis and antimicrobial evaluation of indole containing derivatives of 1,3,4- thiazole, 1,2,4-triazole and their open-chain counterparts. Arzneim forsch., 47, 307-310 (1997) |
6 | Pires, J. R., Saito, C., Gomes, S. L., Giesbrecht, A. M., and Amaral, A. T., Investigation of 5-nitrofuran derivatives: synthesis, antibacterial activity, and quantitative structure-activity relationships. J. Med. Chem., 44, 3673-3681 (2001) DOI ScienceOn |
7 | Gunay, N. S., Capan, G., Ulusoy, N., Ergenc, N., Otuk, G., and Kaya, D., Nitroimidazole derivatives as possible antibacterial and antifungal agents. Farmaco, 54, 826-831 (1999) DOI ScienceOn |
8 | Mamolo, M. G., Vio, L., and Banfi, E., Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4-thiadiazole derivatives. Farmaco, 51, 71-74 (1996) |
9 | Grange, J. M. and Zumla, A., The global emergency of tuberculosis: what is the cause? J. R. Soc. Health, 122, 78-81 (2002) DOI ScienceOn |
10 | Foroumadi, A., Asadipour, A., Mirzaei, M., Karimi, J., and Emami, S., Antituberculosisagents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives. Farmaco, 57, 765-769 (2002) DOI ScienceOn |
11 | Foroumadi, A., Mirzaei, M., and Shafiee A., Antituberculosis agents II: Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives. Farmaco, 56, 621-623 (2001b) DOI ScienceOn |
12 | Foroumadi, A., Daneshtalab, M., and Shafiee, A., Synthesis and in antifungal activity of 2-aryl-5-phenylsulfonyl-1,3,4-thiadiazolederivatives. Arzneim. -Forsch./Drug Res., 49, 1035-1038 (1999) PUBMED |
13 | Collins, L. and Franzblau, S. G., Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium, Antimicrob. Agents Chemother., 41, 1004-1009 (1997) PUBMED |
![]() |